It’s no secret that virtually everyone on earth needs a vaccine for COVID-19, but imagine having to organize the development, production, and distribution. Few companies have to climb that logistical mountain, one of which is Moderna Therapeutics. According to a recent FiercePharma article, the drugmaker has raised its 2021 base-case production estimate from 500 million to 600 million doses, and could potentially hit 1 billion doses. The massive supply goals are in response to increased demand as Moderna recently received expanded orders from Canada, the U.S. and the EU.
Moderna Eyes 1B COVID-19 Vaccine Doses This Year
Moderna Therapeutics is dialing up its low-end manufacturing predictions for the year.
Jan 8, 2021
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
